BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND KMT2D, ENSG00000167548, 8085, MLL2
68 results:

  • 1. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of cancer stem cells.
    Ferrer-Diaz AI; Sinha G; Petryna A; Gonzalez-Bermejo R; Kenfack Y; Adetayo O; Patel SA; Hooda-Nehra A; Rameshwar P
    Cell Commun Signal; 2024 Feb; 22(1):119. PubMed ID: 38347590
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma.
    Yang X; Lian B; Zhang N; Long J; Li Y; Xue J; Chen X; Wang Y; Wang Y; Xun Z; Piao M; Zhu C; Wang S; Sun H; Song Z; Lu L; Dong X; Wang A; Liu W; Pan J; Hou X; Guan M; Huo L; Shi J; Zhang H; Zhou J; Lu Z; Mao Y; Sang X; Wu L; Yang X; Wang K; Zhao H
    BMC Med; 2024 Jan; 22(1):42. PubMed ID: 38281914
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Application value of DNA damage repair variants in adjuvant therapy of triple negative breast cancer].
    Wang X; Yue J; Kang YK; Gao SL; Yuan P
    Zhonghua Zhong Liu Za Zhi; 2023 Sep; 45(9):787-795. PubMed ID: 37805443
    [No Abstract]    [Full Text] [Related]  

  • 5. Genetic analysis of low-grade adenosquamous carcinoma of the breast progressing to high-grade metaplastic carcinoma.
    Kawachi K; Tang X; Kasajima R; Yamanaka T; Shimizu E; Katayama K; Yamaguchi R; Yokoyama K; Yamaguchi K; Furukawa Y; Miyano S; Imoto S; Yoshioka E; Washimi K; Okubo Y; Sato S; Yokose T; Miyagi Y
    Breast Cancer Res Treat; 2023 Dec; 202(3):563-573. PubMed ID: 37650999
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study.
    Park AY; Han MR; Seo BK; Ju HY; Son GS; Lee HY; Chang YW; Choi J; Cho KR; Song SE; Woo OH; Park HS
    Breast Cancer Res; 2023 Jun; 25(1):79. PubMed ID: 37391754
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
    Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
    J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.
    Wang Y; Luo Y; Fu S; He L; Pan G; Fan D; Wen Q; Fan Y
    Front Endocrinol (Lausanne); 2023; 14():1095604. PubMed ID: 37223020
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)-like change: clinicopathological and molecular characteristics.
    Jorns JM; Farooq A; Puzyrenko A; Jarzembowski J; Thike AA; Nasir NDM; Ng CCY; Liu W; Lee JY; Lim AH; Guan P; Teh BT; Tan PH
    Histopathology; 2023 Sep; 83(3):357-365. PubMed ID: 37140543
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Meta-analysis of commonly mutated genes in leptomeningeal carcinomatosis.
    Congur I; Koni E; Onat OE; Tokcaer Keskin Z
    PeerJ; 2023; 11():e15250. PubMed ID: 37096065
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive breast cancer.
    Jones RB; Farhi J; Adams M; Parwani KK; Cooper GW; Zecevic M; Lee RS; Hong AL; Spangle JM
    Cancer Res Commun; 2022 Dec; 2(12):1569-1578. PubMed ID: 36970726
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Camptothecin loaded casein nanosystem for tuning the therapeutic efficacy against highly metastatic triple-negative breast cancer cells.
    Khatun S; Pebam M; Putta CL; Rengan AK
    Biomater Sci; 2023 Mar; 11(7):2518-2530. PubMed ID: 36779378
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DBC1 is a key positive regulator of enhancer epigenomic writers kmt2d and p300.
    Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
    Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
    Tsang JY; Shao Y; Poon IK; Ni YB; Kwan JS; Chow C; Shea KH; Tse GM
    Pathology; 2022 Oct; 54(6):678-685. PubMed ID: 35691725
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genome-wide CRISPR screen identifies PRC2 and kmt2d-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis.
    Zhang Y; Donaher JL; Das S; Li X; Reinhardt F; Krall JA; Lambert AW; Thiru P; Keys HR; Khan M; Hofree M; Wilson MM; Yedier-Bayram O; Lack NA; Onder TT; Bagci-Onder T; Tyler M; Tirosh I; Regev A; Lees JA; Weinberg RA
    Nat Cell Biol; 2022 Apr; 24(4):554-564. PubMed ID: 35411083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Histone Methyltransferase kmt2d Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian cancer.
    Li M; Shi M; Xu Y; Qiu J; Lv Q
    Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.
    Reinisch M; Kuemmel S; Breit E; Theuerkauf I; Harrach H; Schindowski D; Moka D; Bettstetter M; Bruzas S; Chiari O
    Orphanet J Rare Dis; 2021 Aug; 16(1):363. PubMed ID: 34399808
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nuclear Dishevelled targets gene regulatory regions and promotes tumor growth.
    Castro-Piedras I; Sharma M; Brelsfoard J; Vartak D; Martinez EG; Rivera C; Molehin D; Bright RK; Fokar M; Guindon J; Pruitt K
    EMBO Rep; 2021 Jun; 22(6):e50600. PubMed ID: 33860601
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Malignant phyllodes tumour of the breast mimicking endometriosis.
    Lee AHS; Zanetto U; Awasthi R; Hwang MJ; Nasir NDM; Ng CCY; Teh BT; Tan PH
    Virchows Arch; 2021 Nov; 479(5):1051-1053. PubMed ID: 33782741
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MiR-506-3p suppresses papillary thyroid cancer cells tumorigenesis by targeting YAP1.
    Chen L; Wang X; Ji C; Hu J; Fang L
    Pathol Res Pract; 2020 Dec; 216(12):153231. PubMed ID: 33059240
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.